RecruitingPHASE1, PHASE2NCT07473154

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Quell Therapeutics Limited
Intervention
QEL-005(drug)
Enrollment
16 enrolled
Eligibility
18 years · All sexes
Timeline
2026 – 2028

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07473154 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials